No impact of confinement during COVID-19 pandemic on anxiety and depression in Parkinsonian patients.
Rev Neurol (Paris)
; 177(3): 272-274, 2021 Mar.
Article
en En
| MEDLINE
| ID: mdl-33610345
BACKGROUND: Governments around the world have imposed varied containment measures to curb the spread of the COVID-19 infection. The psychological impact could be highly negative in patients with neurologic condition like Parkinson's Disease (PD). METHODS: We prospectively evaluated symptoms of depression and anxiety in 50 (26 females; mean age at 60.4) non demented Moroccan PD patients, using Hospital Anxiety and Depression Scale (HADS), at the beginning and after 6 weeks of a full confinement. RESULTS: At the first evaluation, 28% of patients had depression while 32% had anxiety. After 6 weeks of confinement, some patients got worse and others got better scores but no significant statistical difference for both troubles was seen. CONCLUSION: Our results show that there is no significant impact of 6 weeks of confinement on overall anxiety and depression scores. However, confinement could have an unexpected positive psychological impact on a significant number of PD patients.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Ansiedad
/
Enfermedad de Parkinson
/
Cuarentena
/
Depresión
/
Pandemias
/
COVID-19
Tipo de estudio:
Qualitative_research
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
País/Región como asunto:
Africa
Idioma:
En
Revista:
Rev Neurol (Paris)
Año:
2021
Tipo del documento:
Article
Pais de publicación:
Francia